$28.80
0[0.00%]
At close: May 23
$28.80
0[0.00%]
After Hours: 4:01PM EDT
Sanara MedTech
(NASDAQ:SMTI)Sanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, Predictions
Sanara MedTech Inc has a consensus price target of $51.5, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald on May 15, 2024, March 27, 2024, and February 6, 2024. With an average price target of $45.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 58.56% upside for Sanara MedTech Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sanara MedTech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 52.78% | Cantor Fitzgerald | Ross Osborn | → $44 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | Buy Now | 52.78% | Cantor Fitzgerald | Ross Osborn | $49 → $44 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | 70.14% | Cantor Fitzgerald | Ross Osborn | → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | Buy Now | 70.14% | Cantor Fitzgerald | Ross Osborn | $59 → $49 | Maintains | Overweight | Get Alert |
| 09/26/2023 | Buy Now | 104.86% | Cantor Fitzgerald | Brandon Folkes | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 104.86% | Cantor Fitzgerald | Brandon Folkes | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 08/17/2023 | Buy Now | 104.86% | Cantor Fitzgerald | Brandon Folkes | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 06/30/2021 | Buy Now | 56.25% | Cantor Fitzgerald | Brandon Folkes | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Sanara MedTech (SMTI)?
The latest price target for Sanara MedTech (NASDAQ: SMTI) was reported by Cantor Fitzgerald on May 15, 2024. The analyst firm set a price target for $44.00 expecting SMTI to rise to within 12 months (a possible 52.78% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sanara MedTech (SMTI)?
The latest analyst rating for Sanara MedTech (NASDAQ: SMTI) was provided by Cantor Fitzgerald, and Sanara MedTech reiterated their overweight rating.
When was the last upgrade for Sanara MedTech (SMTI)?
There is no last upgrade for Sanara MedTech.
When was the last downgrade for Sanara MedTech (SMTI)?
There is no last downgrade for Sanara MedTech.
When is the next analyst rating going to be posted or updated for Sanara MedTech (SMTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanara MedTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanara MedTech was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Sanara MedTech (SMTI) correct?
While ratings are subjective and will change, the latest Sanara MedTech (SMTI) rating was a reiterated with a price target of $0.00 to $44.00. The current price Sanara MedTech (SMTI) is trading at is $28.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.